Telmital-Beta 25 Tablet ER
Marketer
Talent India
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Telmital-Beta 25 Tablet ER
Telmital-Beta 25 ER tablets manage hypertension, reducing the risk of strokes and heart attacks. Prompt treatment enhances survival rates following a heart attack. Consistent blood levels are achieved by taking this medication with food at the same time daily, as directed by your physician. Continuous use is crucial; even feeling well, self-discontinuation is dangerous as hypertension is often asymptomatic. Lifestyle changes, including exercise, weight management, and a balanced diet, complement this therapy. Monitor your health closely, adhering to your doctor's guidance. Potential side effects include headache, weakness, lightheadedness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular blood pressure, blood sugar, kidney function, and electrolyte checks are likely. Inform your doctor of pre-existing liver or kidney conditions, or if you are pregnant or breastfeeding. Always disclose all medications, particularly those for hypertension or heart disease.
Uses of Telmital-Beta 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telmital-Beta 25 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmital-Beta 25 Extended-Release Tablet should be administered with a meal.
Common Side effects of Telmital-Beta 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telmital-Beta 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Telmital-Beta 25 Extended-Release Tablet with a meal.
How Telmital-Beta 25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telmital-Beta 25 ER tablets, provide extended-release hypertension management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmital-Beta 25 Tablet ER and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telmital-Beta 25 tablets pose a confirmed risk to a fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telmital-Beta 25 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Telmital-Beta 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telmital-Beta 25 tablets pose no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Extended-release Telmital-Beta 25 tablets require careful administration for individuals with hepatic impairment. Dosage modification of Telmital-Beta 25 ER may be necessary. Physician consultation is advised.
What if you forget to take Telmital-Beta 25 Tablet ER :
Should you forget a Telmital-Beta 25 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmital-Beta 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |



